Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Nuclear Medicine

  Free Subscription


05.10.2026

1 AJNR Am J Neuroradiol
8 Ann Nucl Med
3 Appl Radiat Isot
1 Hum Brain Mapp
1 J Cereb Blood Flow Metab
3 J Nucl Cardiol
8 J Nucl Med
1 Neurology
3 Nucl Med Commun
3 Phys Med Biol
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. QUIGG M, Chernyavskiy P, Terrell W, Smetana R, et al
    Clinical outcomes of dynamic [(18)F]-FDG PET in focal epilepsy: a prospective early observational study.
    AJNR Am J Neuroradiol. 2026 Sep 29:ajnr.A9657. doi: 10.3174/ajnr.A9657.
    PubMed         Abstract available


    Ann Nucl Med

  2. CELIK A, Gultekin A, Sengoz T, Simsek FS, et al
    Baseline Ga-68 PSMA PET/CT-derived volumetric parameters as predictors of biochemical recurrence following radical prostatectomy.
    Ann Nucl Med. 2026 Oct 1. doi: 10.1007/s12149-026-02292.
    PubMed         Abstract available

  3. OGURA D, Kanou M, Toyama T, Koyama K, et al
    Assessment of heart-to-contralateral lung ratios in virtual planar images derived from SPECT using (99m)Tc-pyrophosphate scintigraphy.
    Ann Nucl Med. 2026 Sep 29. doi: 10.1007/s12149-026-02294.
    PubMed         Abstract available

  4. MORITA R, Norikane T, Yamato N, Yamamoto Y, et al
    Comparative diagnostic performance of (1)(8)F-FLT and (1)(8)F-FDG PET for differentiating primary CNS lymphoma from glioblastoma, IDH-wildtype.
    Ann Nucl Med. 2026 Sep 27. doi: 10.1007/s12149-026-02295.
    PubMed         Abstract available

  5. DO AMARAL KM, Siqueira RM, Arab NA, Etchebehere E, et al
    Comparison of metabolic variables in FDG PET/CT in rectal cancer patients who achieved a complete or incomplete response following neoadjuvant chemoradiotherapy.
    Ann Nucl Med. 2026 Sep 26. doi: 10.1007/s12149-026-02285.
    PubMed         Abstract available

  6. KAYA EM, Esen Akkas B, Ulucay M, Aghazada F, et al
    Is early imaging a pitfall? Effect of [(6)(8)Ga]Ga-PSMA PET/CT timing after biopsy on SUVmax and adverse pathology prediction in low-to-intermediate risk prostate cancer.
    Ann Nucl Med. 2026 Sep 26. doi: 10.1007/s12149-026-02288.
    PubMed         Abstract available

  7. GIOVACCHINI G, Agrawal S, Marciano A, Theodore WH, et al
    Assessing metabolic progression in temporal lobe epilepsy: biological and methodological considerations.
    Ann Nucl Med. 2026;40:1245-1252.
    PubMed         Abstract available

  8. MATSUMURA T, Nakajima K, Mizokami A, Wakabayashi H, et al
    Comparison of automated bone scan indexes in patients with prostate cancer: aBSI and BONENAVI.
    Ann Nucl Med. 2026;40:1253-1261.
    PubMed         Abstract available

  9. NAKAJIMA K, Makida S, Okamura M, Kawashiri MA, et al
    Energy spectrum-based correction of washout rates in dual-isotope (123)I-BMIPP/(201)Tl imaging.
    Ann Nucl Med. 2026;40:1197-1209.
    PubMed         Abstract available


    Appl Radiat Isot

  10. AL ROWAILY M, Albakhiti S, Alasmari B, Alruwaili A, et al
    Assessing the effectiveness of (18)F-Fluorocholine PET-CT as the leading imaging technique compared to (99m)Tc-Sestamibi scans and ultrasonography for diagnosing hyperparathyroidism.
    Appl Radiat Isot. 2026;238:112936.
    PubMed         Abstract available

  11. MEISEL Z, Hamad G, Brandenburg K, Brune CR, et al
    Thick-target yield of (65)Cu(alpha,n)(68)Ga near threshold and implications for nuclear medicine, deep underground detector backgrounds, and nucleosynthesis.
    Appl Radiat Isot. 2026;239:112956.
    PubMed         Abstract available

  12. ASLAM MN, Amjed N, Zubia K, Rafique MY, et al
    Theoretical assessment and optimization of cyclotron production routes for high-purity (110m)In for PET applications.
    Appl Radiat Isot. 2026;239:112957.
    PubMed         Abstract available


    Hum Brain Mapp

  13. TARRICONE C, Vallini G, Baron G, Facca M, et al
    Unveiling Functional-Metabolic Synergy in the Healthy Brain: Multivariate Integration of Dynamic [(18)F]FDG-PET and Resting-State fMRI.
    Hum Brain Mapp. 2026;47:e70651.
    PubMed         Abstract available


    J Cereb Blood Flow Metab

  14. SIBAHI A, Hosseini SA, Rahmouni N, Therriault J, et al
    A longitudinal investigation of locus coeruleus norepinephrine system integrity and cognitive performance across the Alzheimer's spectrum.
    J Cereb Blood Flow Metab. 2026;46:2623-2633.
    PubMed         Abstract available


    J Nucl Cardiol

  15. NANEISHVILI T, How WJ, Venetucci L, Arumugam P, et al
    Serial Rubidium-82 PET-CT of the Apical Microvascular Response to Mavacamten in Obstructive Hypertrophic Cardiomyopathy: A Case-Based Report.
    J Nucl Cardiol. 2026 Oct 1:102981. doi: 10.1016/j.nuclcard.2026.102981.
    PubMed        

  16. O'GORMAN KJ, Cohen YA, Bremner L, Mian Z, et al
    Lateral Wall Heterogeneity in (13)N-Ammonia Positron Emission Tomography Scans in Heart Transplant Patients.
    J Nucl Cardiol. 2026 Oct 1:102978. doi: 10.1016/j.nuclcard.2026.102978.
    PubMed         Abstract available

  17. POURBEHI MR, Juweid ME, Jafari E, Jokar N, et al
    FAPI PET Reveals Active Fibroblast-Driven Remodeling Beyond Infarct Scar.
    J Nucl Cardiol. 2026 Oct 1:102979. doi: 10.1016/j.nuclcard.2026.102979.
    PubMed         Abstract available


    J Nucl Med

  18. MAASS A, Garcia-Garcia B, Behrenbruch N, Schumann-Werner B, et al
    Associations of [(18)F]PI-2620 Binding with Memory and Phosphorylated Tau 217 in Cognitively Unimpaired Older Adults.
    J Nucl Med. 2026;67:1652-1660.
    PubMed         Abstract available

  19. ELLS Z, Meyer C, Masri K, Ryhiner M, et al
    Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
    J Nucl Med. 2026 Jul 30:jnumed.126.272574. doi: 10.2967/jnumed.126.272574.
    PubMed         Abstract available

  20. CARAVACA J, Seo Y, Cabello J, Siegel SB, et al
    Clinical Imaging of (225)Ac in a PET Scanner via Time-of-Flight Cascade gamma-Ray Imaging.
    J Nucl Med. 2026 Sep 30:jnumed.126.272594. doi: 10.2967/jnumed.126.272594.
    PubMed         Abstract available

  21. TRAUTWEIN NF, Spogis J, Reischl G, Calderon E, et al
    Head-to-Head Comparison of Neuroblastoma Detection by [(64)Cu]GD2 PET and [(123)I]MIBG SPECT.
    J Nucl Med. 2026 Sep 30:jnumed.126.272350. doi: 10.2967/jnumed.126.272350.
    PubMed         Abstract available

  22. PIRES M, Gutschmayer S, Bergalla E, Chauvie S, et al
    Fully Automated Segmentation of [(18)F]FDG and [(68)Ga]/[(18)F]PSMA PET/CT Images via Data-Centric Deep Learning.
    J Nucl Med. 2026 Sep 30:jnumed.126.272852. doi: 10.2967/jnumed.126.272852.
    PubMed         Abstract available

  23. LIN W, Chen J, Ran W, Xu H, et al
    Nectin-4-Targeted PET/CT Before Organ-Sacrificing Surgery for Occult Ureteral Carcinoma.
    J Nucl Med. 2026 Sep 30:jnumed.126.273397. doi: 10.2967/jnumed.126.273397.
    PubMed        

  24. GODARA ML, Tekin V, Houson HA, Dufour G, et al
    Evaluation of the In Vivo PET Generator (140)Nd/(140)Pr Using a HER2-Targeting Agent.
    J Nucl Med. 2026 Sep 30:jnumed.126.272952. doi: 10.2967/jnumed.126.272952.
    PubMed         Abstract available


  25. Advancing Nuclear Medicine Through Patient Voices.
    J Nucl Med. 2026;67:4A.
    PubMed        


    Neurology

  26. SHIR D, Algeciras-Schimnich A, Piura YD, Bornhorst JA, et al
    Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers.
    Neurology. 2026;107:e218591.
    PubMed         Abstract available


    Nucl Med Commun

  27. ENISELER EB, Ekinci F, Sahbazlar M, Erdogan AP, et al
    PET-derived metabolic-immunonutritional SUVmax-lactate dehydrogenase-albumin-lymphocyte index for survival prediction in human epidermal growth factor receptor 2-positive metastatic breast cancer receiving pertuzumab-based therapy.
    Nucl Med Commun. 2026 Sep 29. doi: 10.1097/MNM.0000000000002237.
    PubMed         Abstract available

  28. YAN G, Hu N, Ran M, Liu S, et al
    PET/CT-based deep learning for differentiating squamous cell carcinoma from adenocarcinoma in non-small cell lung cancer: comparison of multimodal fusion strategies.
    Nucl Med Commun. 2026 Sep 24. doi: 10.1097/MNM.0000000000002236.
    PubMed         Abstract available

  29. JIANG F, Liu S, Liu C, Zhang W, et al
    18F-FDG PET/CT radiomics for prediction of BRCA mutations in high-grade serous ovarian cancer.
    Nucl Med Commun. 2026 Sep 22. doi: 10.1097/MNM.0000000000002245.
    PubMed         Abstract available


    Phys Med Biol

  30. ZENG T, Najmaoui Y, Zhang J, Volpi T, et al
    Impact of depth-of-interaction and spatially-variant point-spread-function model on the performance of ultra-high resolution brain PET.
    Phys Med Biol. 2026 Oct 2. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  31. ZHANG Q, Liu Z, Deng T, Chen J, et al
    Decay-time correction for dual-panel in-beam PET monitoring of carbon-ion SOBP irradiation.
    Phys Med Biol. 2026 Oct 1. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  32. BUI MHH, Robert A, Badel JN, Etxebeste A, et al
    Detection and correction of rigid patient motion in SPECT with exponential data consistency conditions.
    Phys Med Biol. 2026 Sep 29. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  33. TOMASI D, Volkow ND
    Reproducible cortical links between functional hierarchy, structure, and metabolism.
    Proc Natl Acad Sci U S A. 2026;123:e2614926123.
    PubMed         Abstract available

  34. ZOGHBI SS, Innis RB
    Potential vascular confound in GPR84-PET imaging following systemic LPS administration.
    Proc Natl Acad Sci U S A. 2026;123:e2619004123.
    PubMed        

  35. KALITA M, Kuo RC, Reyes ST, Scott PJH, et al
    Reply to Zoghbi and Innis: Clarifying the cellular basis of GPR84-PET signal in neuroinflammation.
    Proc Natl Acad Sci U S A. 2026;123:e2623658123.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum